Comparison

Bi 2536

Item no. DCC-DC7083-250mg
Manufacturer DCChemicals
CASRN 755038-02-9
Amount 250 mg
Quantity options 100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category
Type Inhibitors
Applications IC
Specific against other
Purity >98%
Smiles O=C1[C@@]([H])(C([H])([H])C([H])([H])[H])N(C2C(=C([H])N=C(N([H])C3C([H])=C([H])C(=C([H])C=3OC([H])([H])[H])C(N([H])C3([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C3([H])[H])=O)N=2)N1C([H])([H])[H])C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BI-2536,BI2536
Similar products 755038-02-9
Available
Manufacturer - Applications
BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3; BI2536 also is a BRD4 inhibitor(IC50= 25 nM).
Storage Conditions
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight
521, 6544
Note
For research only, not for human use.
Chemical name
(R)-4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5, 6, 7, 8-tetrahydropteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close